Testing effectiveness (Phase 2)Active Not RecruitingNCT03040973
What this trial is testing
Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone
Who this might be right for
Advanced Solid Tumors Which Are cMET-dependent
Novartis Pharmaceuticals 29